Citation Impact
Citing Papers
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Epidemiology and causes of preterm birth
2008 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
The implications of angiogenesis for the biology and therapy of cancer metastasis
1994 Standout
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
Transvascular drug delivery in solid tumors
1998
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
New trends in photobiology photosensitization of mitochondria. Molecular and cellular aspects
1990
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
2012 Standout
Multistage Nanoparticles for Improved Delivery into Tumor Tissue
2012 StandoutNobel
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Drug penetration in solid tumours
2006 Standout
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
The metabolic syndrome
2010 Standout
Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
2012
An overview of mortality and sequelae of preterm birth from infancy to adulthood
2008 Standout
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
2003 Standout
Very preterm birth–a regional study. Part 2: The very preterm infant
1996
Nanoparticles in cancer therapy and diagnosis
2002 Standout
Mechanisms of Focal Heat Destruction of Liver Tumors
2005
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
2007 Standout
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
2005 Standout
Non‐alcoholic fatty liver disease: An overview
2002
Delivery technologies for cancer immunotherapy
2019 Standout
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
The metabolic syndrome
2005 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
High interstitial fluid pressure — an obstacle in cancer therapy
2004 Standout
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Long‐term follow‐up of patients with NAFLD and elevated liver enzymes†‡
2006 Standout
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
2010 Standout
Decreased disability rate among 3-year-old survivors weighing 501 to 1000 grams at birth and born to residents of a geographically defined region from 1981 to 1984 compared with 1977 to 1980
1989
Very preterm birth–a regional study. Part 1: Maternal and obstetric factors
1996
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Transport of molecules across tumor vasculature
1987
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
2012 Standout
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Stable polymeric micelles: Lymphangiographic contrast media for gamma scintigraphy and magnetic resonance imaging
1996
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Gold Nanorods: From Synthesis and Properties to Biological and Biomedical Applications
2009 Standout
Obesity in children and young people: a crisis in public health
2004 Standout
Cellular markers that distinguish the phases of hemangioma during infancy and childhood.
1994 Standout
Hepatocellular Carcinoma
2011 Standout
Surgery Decreases Long-term Mortality, Morbidity, and Health Care Use in Morbidly Obese Patients
2004 Standout
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
2005 Standout
Reduction of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein.
1987
Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
1989 StandoutScience
The EPICure Study: Outcomes to Discharge From Hospital for Infants Born at the Threshold of Viability
2000 Standout
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
2001 Standout
Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors
1998
Peritioneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors
1989 Standout
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Malignant Ascites
1986
Microvascular permeability of normal and neoplastic tissues
1986
Sexually Transmitted Diseases and Adverse Outcomes of Pregnancy
1997
Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules.
1988
The Control of Diabetes Mellitus (NIDDM) in the Morbidly Obese with the Greenville Gastric Bypass
1987
Treatment of unresectable hepatocellular carcinoma : Results of a randomized controlled trial
1986
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan
2001 Standout
The biology of cancer metastasis and implications for therapy
1987
The Chemistry of Neutron Capture Therapy
1998 Standout
Meta-Analysis: Surgical Treatment of Obesity
2005 Standout
Sustained coronary-risk-factor reduction after gastric bypass for morbid obesity
1990
Changes of Vascular Pattern of Tumors and Surrounding Tissue During Different Phases of Metastatic Growth
1986
New Compounds: Organoboron Derivatives of Tetracyclines I: Synthesis of Carboxamido Derivative of Tetracycline with Perhydro-2-phenyl-l,3,6,2-dioxazaborocine
1977
Surgery for weight loss in adults
2014 Standout
Analysis of nanoparticle delivery to tumours
2016 Standout
The clinical effectiveness and cost-effectiveness of surgery for people with morbid obesity: a systematic review and economic evaluation
2002
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Liposomal Blockade of the Reticuloendothelial System: Improved Tumor Imaging with Small Unilamellar Vesicles
1983 Science
Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model.
1987
A practical score for the early diagnosis of acute appendicitis
1986 Standout
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
1998 Standout
Works of Ackerman Nb being referenced
Studies on the capillary permeability of experimental liver metastases.
1978
The effects of cooling, freezing and thawing on vascular permeability and perfusion in experimental liver metastases.
1981
The technique of primary arterial ligation for cancer of the colon as suggested by venous and lymphatic outflow studies.
1976
Tetracycline fluorescence in benign and malignant tissues.
1963
Survival and short-term morbidity of the premature neonate.
1985
The influences of mechanical factors on intestinal lymph flow and their relationship to operations for carcinoma of the intestine.
1974
Protein supplementation in the management of degenerating liver function after jejunoileal bypass.
1979
Observations on the improvements in carbohydrate metabolism in diabetic and other morbidly obese patients after jejunoileal bypass.
1981
The blood supply of experimental liver metastases. 3. The effects of acute ligation of the hepatic artery or portal vein.
1972
Comparisons of vascular permeability of tumors and liver host tissue.
1977
Changes in serum cholesterol and triglyceride levels after jejunoileal and gastric bypasses in morbidly obese patients.
1982
Differences in vascular permeability between normal and tumor vessels produced by vasoactive agents.
1973
The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth.
1974
The continuing problems of perforated appendicitis.
1974
Failure of histamine type mediators to enhance vascular permeability in experimental liver metastases.
1980